
Here's what COVID vaccines are worth to Big Pharma
Developing the vaccines was a gamble for the all the companies that tried, even with most drug makers accepting government grands.
Developing the vaccines was a gamble for the all the companies that tried, even with most drug makers accepting government grands.
In the winter of 1991, Karen Lynch sat by her Aunt Millie’s hospital bed. Lynch wasn’t the eldest of her family’s four siblings, but in the 16 years since their mother’s death, the 28-year-old had become Millie’s primary caretaker.When a priest arrived to deliver Millie’s last rites, Lynch was the only family member present. Hospital staff escorted her out of the room for the ceremony but brought her back in when Millie, fiery to her last days, protested.
New York (CNN Business)The various Covid-19 vaccines currently being distributed around the globe have the potential to end the worst pandemic in a century. They also will mean hundreds of billions dollars in sales for the pharmaceutical companies that make them.
PROVIDENCE, R.I. (AP) — The road to a COVID-19 shot often leads through a maze of scheduling systems: Some vaccine seekers spend days or weeks trying to book online appointments. Those who get a coveted slot can still be stymied by pages of forms or websites that slow to a crawl and crash.
Public health efforts almost eradicated Guinea worm disease in humans. However, a few years ago, researchers realized the disease had become prevalent in dogs – and could cross back over into human populations. To prevent the disease from roaring back, researchers are now developing computational models they can use to drive down disease occurrence in man’s best friend.
Ashley Smith
Public Affairs Coordinator
INFORMS
Catonsville, MD
[email protected]
443-757-3578
An audio journey of how data and analytics save lives, save money and solve problems.
Can we really trust AI to make better decisions than humans? A new study says … not always. Researchers have discovered that OpenAI’s ChatGPT, one of the most advanced and popular AI models, makes the same kinds of decision-making mistakes as humans in some situations—showing biases like overconfidence of hot-hand (gambler’s) fallacy—yet acting inhuman in others (e.g., not suffering from base-rate neglect or sunk cost fallacies).
The genetic testing company 23andMe, which holds the genetic data of 15 million people, declared bankruptcy on Sunday night after years of financial struggles. This means that all of the extremely personal user data could be up for sale—and that vast trove of genetic data could draw interest from AI companies looking to train their data sets, experts say.
Robert F. Kennedy Jr., as the new secretary of Health and Human Services, is the nation’s de facto healthcare czar. He will have influence over numerous highly visible agencies, including the Centers for Disease Control and Prevention, the National Institutes of Health and the Food and Drug Administration, among others. Given that healthcare is something that touches everyone’s life, his footprint of influence will be expansive.
Health insurance has become necessary, with large and unpredictable health care costs always looming before each of us. Unfortunately, the majority of people have experienced problems when using their health insurance to pay for their medical care. Health insurance serves as the buffer between patients and the medical care system, using population pooling to mitigate the risk exposure on any one individual.
Oklahoma State University's Sunderesh Heragu joins LiveNOW's Austin Westfall to discuss the evolving economic landscape after President Trump implemented tariffs on some of our biggest trade partners. Most tariffs have been halted for now -- but not with China. Beijing and the White House have levied steep tariffs on each other. Trump announced that tariffs on China would reach 145 percent. In response, China imposed 125 percent tariffs on U.S.-imported goods.
Washington’s experiment with tariff trade torment makes lab costs soar; ‘it’s like doubling the price tag’, US researcher says
In the case of upgrading electrical and broadband infrastructure, new analysis from the University of Massachusetts Amherst reveals {that a} “dig once” strategy is almost 40% more economical than changing them individually.
Billionaire investor Mark Cuban's question to Representative Matt Gaetz, a Florida Republican, on energy costs took off on social media on Saturday.